Sucrose acetate isobutyrate (SAIB) and glyceryl monooleate (GMO) hybrid nanoparticles for bioavailability enhancement of rivaroxaban: an optimization study
- PMID: 37870222
- DOI: 10.1080/10837450.2023.2274944
Sucrose acetate isobutyrate (SAIB) and glyceryl monooleate (GMO) hybrid nanoparticles for bioavailability enhancement of rivaroxaban: an optimization study
Abstract
This study aims to improve the RXB bioavailability using hybrid nanoparticles. A modified melt dispersion technique created different formulas with varying GMO-SAIB: RXB and GMO: SAIB ratios, with fixed GMO-SAIB: poloxamer 407 ratios. The PS, PDI, ZP, and EE were measured to determine the optimal formula, which was selected using Design-Expert™ software. The optimized formula was lyophilized and tested for PS, PDI, ZP, and EE. The chosen lyophilized formula (L4) was characterized using FTIR, DSC, PXRD, dissolution studies, and pharmacokinetics studies. The study found correlations between variables and identified how GMO-SAIB concentration affects drug encapsulation. The dissolution parameters were calculated, including % Q5 and % DE). The % Q5 values were 68.4 ± 1.7% and 89.7 ± 3.6% for Xarelto and L4 tablets, respectively. The % DE values were 89.7 ± 0.4% and 97.5 ± 2.1% for Xarelto and L4 tablets, respectively. The AUC values were 2117.0 ng.h/mL (±77.3) and 3919.4 ng.h/mL (±134.8) for Xarelto and L4 tablets, respectively. The Cmax values were 241.3 ng/mL (±21.0) and 521.5 ng/mL (±91.5) for Xarelto and L4 tablets, respectively. In conclusion, the study found that using GMO-SAIB as co-formers effectively enhanced the bioavailability of RXB. The authors recommend using the hybrid nanoparticles technique and suggest further research to enhance its effectiveness for drug delivery.
Keywords: Nanonization; bioavailability enhancement; glyceryl monooleate; rivaroxaban; sucrose acetate isobutyrate.
Similar articles
-
Sustained release and enhanced oral bioavailability of rivaroxaban by PLGA nanoparticles with no food effect.J Thromb Thrombolysis. 2020 Apr;49(3):404-412. doi: 10.1007/s11239-019-02022-5. J Thromb Thrombolysis. 2020. PMID: 31898270
-
Electrosprayed naringin-loaded microsphere/SAIB hybrid depots enhance bone formation in a mouse calvarial defect model.Drug Deliv. 2019 Dec;26(1):137-146. doi: 10.1080/10717544.2019.1568620. Drug Deliv. 2019. PMID: 30799644 Free PMC article.
-
[Preparation and evaluation of risperidone-loaded microsphere/sucrose acetate isobutyrate in situ forming complex depot with double diffusion barriers].Yao Xue Xue Bao. 2015 Jun;50(6):775-82. Yao Xue Xue Bao. 2015. PMID: 26521452 Chinese.
-
Metabolism and pharmacokinetics of sucrose acetate isobutyrate (SAIB) and sucrose octaisobutyrate (SOIB) in rats, dogs, monkeys or humans: a review.Food Chem Toxicol. 1998 Feb;36(2):95-9. doi: 10.1016/s0278-6915(97)00123-3. Food Chem Toxicol. 1998. PMID: 9519847 Review.
-
Sucrose acetate isobutyrate (SAIB): historical aspects of its use in beverages and a review of toxicity studies prior to 1988.Food Chem Toxicol. 1998 Feb;36(2):81-93. doi: 10.1016/s0278-6915(97)80300-6. Food Chem Toxicol. 1998. PMID: 9519846 Review.
Cited by
-
Enhanced Antibacterial Activity of Clindamycin Using Molecularly Imprinted Polymer Nanoparticles Loaded with Polyurethane Nanofibrous Scaffolds for the Treatment of Acne Vulgaris.Pharmaceutics. 2024 Jul 17;16(7):947. doi: 10.3390/pharmaceutics16070947. Pharmaceutics. 2024. PMID: 39065644 Free PMC article.
-
Formulation, optimization and evaluation of ocular gel containing nebivolol Hcl-loaded ultradeformable spanlastics nanovesicles: In vitro and in vivo studies.Int J Pharm X. 2024 Jan 16;7:100228. doi: 10.1016/j.ijpx.2023.100228. eCollection 2024 Jun. Int J Pharm X. 2024. PMID: 38317829 Free PMC article.
-
Green Synthesis of Zinc Oxide Nanoparticles from Althaea officinalis Flower Extract Coated with Chitosan for Potential Healing Effects on Diabetic Wounds by Inhibiting TNF-α and IL-6/IL-1β Signaling Pathways.Int J Nanomedicine. 2024 Mar 27;19:3045-3070. doi: 10.2147/IJN.S455270. eCollection 2024. Int J Nanomedicine. 2024. PMID: 38559447 Free PMC article.
-
Oral Bioavailability Enhancement of Poorly Soluble Drug by Amorphous Solid Dispersion Using Sucrose Acetate Isobutyrate.AAPS PharmSciTech. 2024 Sep 5;25(7):202. doi: 10.1208/s12249-024-02924-5. AAPS PharmSciTech. 2024. PMID: 39237685
MeSH terms
Substances
LinkOut - more resources
Full Text Sources